Literature DB >> 1773041

HBNF and MK, members of a novel gene family of heparin-binding proteins with potential roles in embryogenesis and brain function.

P Böhlen1, I Kovesdi.   

Abstract

HBNF (heparin-binding neurite-promoting factor) is a heparin-binding protein which is found primarily in the brain and stimulates neurite outgrowth in cultured perinatal neurons. It was also reported to be mitogenic for fibroblasts and endothelial cells but this activity is still controversial. The sequence of HBNF is highly conserved in diverse species suggesting important function. Expression of the HBNF gene in brain tissue appears to be developmentally regulated, increasing during gestation to highest levels around the time of birth. The HBNF gene shows high sequence homology to another gene, MK (midkine). Like HBNF, the MK gene is developmentally regulated, however, high expression occurs in most fetal tissues during mid-gestation. The biological properties of the MK protein are remarkably similar to those of HBNF. The available evidence suggests that HBNF and MK are members of a new family of genes with potential roles in fetal development and in brain function or maintenance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1773041     DOI: 10.1016/s0955-2235(05)80005-5

Source DB:  PubMed          Journal:  Prog Growth Factor Res        ISSN: 0955-2235


  16 in total

1.  PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis.

Authors:  Z Z Su; N I Goldstein; H Jiang; M N Wang; G J Duigou; C S Young; P B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

2.  Dominant negative pleiotrophin induces tetraploidy and aneuploidy in U87MG human glioblastoma cells.

Authors:  Yunchao Chang; James R Berenson; Zhaoyi Wang; Thomas F Deuel
Journal:  Biochem Biophys Res Commun       Date:  2006-10-05       Impact factor: 3.575

3.  Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus.

Authors:  A M Schulte; S Lai; A Kurtz; F Czubayko; A T Riegel; A Wellstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 4.  Pleiotrophin: Activity and mechanism.

Authors:  Xu Wang
Journal:  Adv Clin Chem       Date:  2020-03-12       Impact factor: 5.394

5.  Upregulation of heparin-affin regulatory peptide by androgen.

Authors:  F Vacherot; K Laaroubi; D Caruelle; J Delbe; D Barritault; J P Caruelle; J Courty
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-10       Impact factor: 2.416

6.  Pleiotrophin deletion alters glucose homeostasis, energy metabolism and brown fat thermogenic function in mice.

Authors:  Julio Sevillano; María Gracia Sánchez-Alonso; Begoña Zapatería; María Calderón; Martín Alcalá; María Limones; Jimena Pita; Esther Gramage; Marta Vicente-Rodríguez; Daniel Horrillo; Gema Medina-Gómez; María Jesús Obregón; Marta Viana; Ismael Valladolid-Acebes; Gonzalo Herradón; María Pilar Ramos-Álvarez
Journal:  Diabetologia       Date:  2018-10-16       Impact factor: 10.122

Review 7.  Molecular and pharmacologic targeting of angiogenesis factors--the example of pleiotrophin.

Authors:  F Czubayko; A M Schulte; S C Missner; S S Hsieh; K J Colley; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

Review 8.  The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.

Authors:  A T Riegel; A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 9.  Growth factor targeted and conventional therapy of breast cancer.

Authors:  A Wellstein
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Analysis of the structure and neuritogenic activity of chondroitin sulfate/dermatan sulfate hybrid chains from porcine fetal membranes.

Authors:  Taishi Hashiguchi; Shuji Mizumoto; Shuhei Yamada; Kazuyuki Sugahara
Journal:  Glycoconj J       Date:  2009-08-29       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.